SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-054723
Filing Date
2021-02-24
Accepted
2021-02-24 16:34:51
Documents
5
Period of Report
2021-02-24
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d101283d8k.htm 8-K 56802
2 EX-3.1 d101283dex31.htm EX-3.1 6901
3 EX-3.2 d101283dex32.htm EX-3.2 5129
4 EX-99.1 d101283dex991.htm EX-99.1 16414
5 GRAPHIC g101283g62b51.jpg GRAPHIC 2939
  Complete submission text file 0001193125-21-054723.txt   91138
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 21673877
SIC: 2834 Pharmaceutical Preparations